clOpidogrel resIstaNce in a Selected Population of Patients at a Tertiary Cardiovascular Center in Trinidad - Trial NCT03667066
Access comprehensive clinical trial information for NCT03667066 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of The West Indies and is currently Completed. The study focuses on Platelet Dysfunction. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of The West Indies
Timeline & Enrollment
N/A
Sep 01, 2017
Jun 01, 2018
Primary Outcome
Overall prevalence of HPR in the Trinidadian population undergoing elective percutaneous coronary intervention
Summary
The aim of this study was to determine the prevalence of clopidogrel resistance among a
 selected group of patients undergoing elective percutaneous coronary intervention and to
 observe whether there was any south-Asian (Indo-Trinidadian) predilection for HPR considering
 the well-established epidemiologic trends for accelerated CAD within this subgroup.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03667066
Non-Device Trial